Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
MD 
Mednax Inc (MD)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
06/30/2025: MD (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
8 Analysts rated it
Moderately tracked stock, growing coverage, gaining market and investor attention.
1 Year Target Price $17.14
1 Year Target Price $17.14
| 3 | Strong Buy |
| 0 | Buy |
| 5 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -1.84% | Avg. Invested days 36 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 06/30/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 1.21B USD | Price to earnings Ratio - | 1Y Target Price 17.14 |
Price to earnings Ratio - | 1Y Target Price 17.14 | ||
Volume (30-day avg) 8 | Beta 1.27 | 52 Weeks Range 6.62 - 17.67 | Updated Date 06/30/2025 |
52 Weeks Range 6.62 - 17.67 | Updated Date 06/30/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -1 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -4.17% | Operating Margin (TTM) 8.44% |
Management Effectiveness
Return on Assets (TTM) 5.95% | Return on Equity (TTM) -10.01% |
Valuation
Trailing PE - | Forward PE 8.55 | Enterprise Value 1641397462 | Price to Sales(TTM) 0.61 |
Enterprise Value 1641397462 | Price to Sales(TTM) 0.61 | ||
Enterprise Value to Revenue 0.83 | Enterprise Value to EBITDA 69.27 | Shares Outstanding 85905696 | Shares Floating 83143378 |
Shares Outstanding 85905696 | Shares Floating 83143378 | ||
Percent Insiders 2.11 | Percent Institutions 92.23 |
Analyst Ratings
Rating 3 | Target Price 17.14 | Buy - | Strong Buy 3 |
Buy - | Strong Buy 3 | ||
Hold 5 | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Mednax Inc
Company Overview
History and Background
Mednax Inc., formerly known as Pediatrix Medical Group, was founded in 1979. Initially focused on neonatal physician services, it has expanded to offer a broader range of maternal-fetal and pediatric subspecialty care through a network of affiliated physicians. Significant milestones include numerous acquisitions and strategic expansions into related healthcare services.
Core Business Areas
- Obstetrics and Pediatrics: Provides physician services including obstetrics and gynecology, maternal-fetal medicine, neonatology and other pediatric subspecialties.
Leadership and Structure
Mednax Inc. is led by a Board of Directors and executive management team. Specific individuals can be found on their investor relations page. The organizational structure is typical of a publicly traded company with defined departments for operations, finance, marketing, and human resources.
Top Products and Market Share
Key Offerings
- Neonatology Services: Provision of neonatal care in hospital NICUs. Mednax has a substantial market share in this segment (Difficult to determine exact number without access to specialized data, estimated in the double digits based on market reporting, needs more recent info), with competitors including hospital-employed physicians and other private groups.
- Maternal-Fetal Medicine: Management of high-risk pregnancies and delivery services. Market share is also significant but difficult to pinpoint exactly without specialized industry reports. Competitors include other private physician groups and hospital systems.
Market Dynamics
Industry Overview
The market for specialized physician services, particularly in maternal and pediatric care, is driven by factors such as birth rates, prevalence of high-risk pregnancies, and increasing demand for specialized medical expertise. The industry faces challenges related to reimbursement pressures, regulatory changes, and consolidation trends.
Positioning
Mednax is a leading national provider of physician services. Its competitive advantages include its large network of affiliated physicians, established reputation, and expertise in specialized areas. The company differentiates itself through quality of care and focus on patient outcomes.
Total Addressable Market (TAM)
The TAM for maternal and pediatric physician services is estimated to be substantial, potentially tens of billions of dollars annually. Mednax holds a portion of this TAM, with opportunities to expand through organic growth and strategic acquisitions.
Upturn SWOT Analysis
Strengths
- Large national network of physicians
- Established reputation and brand recognition
- Expertise in specialized medical fields
- Strong relationships with hospitals
- Focus on quality of care
Weaknesses
- High debt levels
- Exposure to reimbursement pressures
- Dependence on acquisitions for growth
- Potential for litigation related to medical malpractice
- Turnover of Physicians
Opportunities
- Expansion into new geographic markets
- Development of new service lines
- Increased demand for specialized medical care
- Strategic partnerships with other healthcare providers
- Leveraging technology to improve efficiency and patient outcomes
Threats
- Changes in healthcare regulations and reimbursement policies
- Increased competition from other physician groups and hospital systems
- Rising costs of medical malpractice insurance
- Economic downturns that reduce patient demand
- Difficulty in attracting and retaining qualified physicians
Competitors and Market Share
Key Competitors
- USPH
- TEAM
- AMN
Competitive Landscape
Mednax faces competition from other physician groups, hospital systems, and staffing companies. Its advantages include its scale and expertise, while its disadvantages may include its debt load and reliance on acquisitions.
Growth Trajectory and Initiatives
Historical Growth: Mednax's historical growth has been driven by a combination of organic growth and acquisitions. The company has expanded its service offerings and geographic footprint over time.
Future Projections: Future growth prospects depend on factors such as industry trends, economic conditions, and the company's ability to execute its strategic initiatives. Analyst estimates can vary depending on the specific source.
Recent Initiatives: Recent strategic initiatives may include focusing on core specialties, reducing debt, and improving operational efficiency.
Summary
Mednax Inc. is a leading provider of specialized physician services, particularly in maternal and pediatric care. The company's strengths include its large network of physicians and established reputation. However, it faces challenges related to reimbursement pressures and debt levels. Mednax needs to strategically navigate the changing healthcare landscape to sustain growth and profitability.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Website
- SEC Filings
- Industry Reports
- Financial News Sources
Disclaimers:
This analysis is based on publicly available information and is for informational purposes only. It is not financial advice, and readers should consult with a qualified financial advisor before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Mednax Inc
Exchange NYSE | Headquaters Sunrise, FL, United States | ||
IPO Launch date 1995-09-19 | CEO & Executive Chairman Mr. Mark S. Ordan | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 4120 | Website https://www.pediatrix.com |
Full time employees 4120 | Website https://www.pediatrix.com | ||
Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians, including maternal-fetal medicine nurse practitioners, certified nurse mid-wives, sonographers, and genetic counselors. In addition, it offers other pediatric subspecialty care services, such as pediatric intensivists, pediatric hospitalists, pediatric surgeons, and other newborn and pediatric care, as well as newborn hearing screening, and support services in hospitals, pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.